Taking duloxetine and Wegovy together: the facts

The misconception worth clearing up first

A common assumption circulates online: that antidepressants and GLP-1 medicines simply cannot be taken together, full stop. That is not what the clinical evidence shows, and it can stop people from even raising the question with a prescriber, which is the one conversation they genuinely need to have.

The reality is more specific. Wegovy slows gastric emptying. That is central to how it reduces appetite and aids weight loss. But slowing how quickly food and liquid leave your stomach can also affect how quickly oral medicines are absorbed into your bloodstream. For most medicines the effect is modest. For a few, timing and consistency of absorption matters enough to monitor. Duloxetine is an oral medicine taken daily, so this is worth flagging, not as a reason to avoid the combination, but as information your prescriber uses to review your care properly.

The NHS patient information for semaglutide notes that Wegovy may affect the absorption of other oral medicines and advises telling your healthcare team about everything you take. That instruction is genuinely important here.

What duloxetine does to appetite and weight, and why it complicates the picture

Duloxetine, an SNRI (serotonin-norepinephrine reuptake inhibitor), is prescribed primarily for depression, generalised anxiety disorder, and certain pain conditions. Its effect on weight varies considerably between people. Some find it weight-neutral; others notice gradual gain, particularly over longer-term use. A minority experience appetite changes in either direction. There is no single pattern.

This matters when you are considering a weight-management medicine. A prescriber reviewing your suitability for Wegovy will want to understand whether any weight gain you are hoping to address is partly influenced by your antidepressant, how stable your mental health is, and whether any dose adjustments to duloxetine are planned. The two medicines do not simply cancel each other out; they each have their own trajectory, and the prescriber is mapping both.

Nausea is worth particular attention. Duloxetine can cause nausea, especially early on or after a dose change. Wegovy commonly causes nausea too, typically in the first weeks of treatment or after a dose increase. That overlap does not make the combination impossible, but it is worth anticipating and discussing, and our Wegovy rage page covers the broader range of mood and behavioural changes that some people experience on semaglutide. The NHS England guidance on weight-management injections is a useful reference on what to expect from semaglutide at each stage.

The serotonin question, and why it is less alarming than it sounds

Some people reading about this combination encounter the term serotonin syndrome and worry. Serotonin syndrome is a potentially serious condition caused by excess serotonin activity, usually when multiple serotonin-affecting medicines are combined at high doses. GLP-1 receptor agonists like semaglutide are not primarily serotonergic medicines. They act on GLP-1 receptors in the gut and brain, not on serotonin transporters. The pharmacological mechanism that drives serotonin syndrome risk with duloxetine is not shared by Wegovy in the same way it would be with, say, an MAOI or tramadol.

That said, putting a label on why the specific risk is lower is not the same as clearing the combination without review. Your prescriber considers your full medicines list, your doses, and any other factors relevant to your health. If you are curious about how semaglutide compares to other GLP-1 options in terms of interactions, the dulaglutide and semaglutide page covers some of the class-level considerations in more detail.

Getting assessed when you are already taking duloxetine

People on long-term antidepressants sometimes wonder whether it is even worth starting the process of seeking a weight-management medicine. It absolutely is. Being on duloxetine does not disqualify you from Wegovy, and weight management can itself have a meaningful positive effect on mood and energy, something that works alongside, not against, mental health care.

What changes is the information you bring to the consultation. List your duloxetine dose, how long you have been taking it, and who prescribes it. At nume, a GPhC-registered Independent Prescriber reads your full consultation (a real clinician, not an automated system) and considers your complete medicines history before reaching any decision. You can explore what private Wegovy treatment costs in the UK and read more about the broader treatment options on the weight-loss treatment overview page.

It is also worth keeping your GP informed. If your duloxetine is prescribed by your GP, letting them know you are starting a GLP-1 medicine means both sides of your care are joined up. That is straightforward common sense, and our prescribers encourage it as standard. If you want to read about other medicine combinations that come up frequently in this context, including questions about supplements such as l-carnitine taken alongside semaglutide, we cover those in dedicated pages, the fluoxetine and semaglutide page covers similar ground for another widely used antidepressant, and our Wegovy overview sets out the full clinical picture for semaglutide as a weight-management medicine.